← All stocks

PRECISION BIOSCIENCES INC

DTIL Net buying
CIK 0001357874 #3786 in the set updated 18 Sep 2026
Bought (12 mo)
$53.98K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$466.17K
$402.94K on a plan · $63.23K straight out of an exercise
Sold at will
$0.00
0 of 11 sales
Net
−$412.19K
+$53.98K against sales at will

By person

9 insiders · 16 transactions
1.4×

Michael Amoroso holds only 1.4 times base salary in stock. $934.63K of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $3.84, the price Common Stock was last bought or sold at on the open market here, on 18 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Amoroso Michael
President and CEO
$246.18K (3) scheduled
−$246.18K
243,392
$934.63K
+1,001%
Kelly John Alexander
Chief Financial Officer
$101.06K (3) scheduled
−$101.06K
125,883
$483.39K
+259.3%
SMITH J. JEFFERSON
Chief Research Officer
$60.02K (2) scheduled
−$60.02K
121,926
$468.20K
+69.4%
Scimeca Dario
General Counsel and Secretary
$58.91K (3) scheduled
−$58.91K
56,457
$216.79K
+540.9%
Frankel Stanley
Director
$26.11K (2)
+$26.11K
40,478
$155.44K
+852.0%
Germano Geno J
Director
$14.16K (1)
+$14.16K
44,883
$172.35K
+968.1%
Brown Melinda
Director
$13.71K (2)
+$13.71K
44,346
$170.29K
+955.4%
Buehler Kevin
Director
49,137
$188.69K
+1,019%
Pire Shari Lisa
Director
35,028
$134.51K
+733.6%

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 7,671,059 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SMITH J. JEFFERSON
18 Feb 2026
Chief Research Officer
Sold on a plan
4,925
$3.84
$18.91K
Scimeca Dario
18 Feb 2026
General Counsel and Secretary
Sold on a plan
4,925
$3.84
$18.91K
Kelly John Alexander
18 Feb 2026
Chief Financial Officer
Sold on a plan
8,149
$3.84
$31.29K
Amoroso Michael
18 Feb 2026
President and CEO
Sold on a plan
20,559
$3.84
$78.95K
Amoroso Michael
22 Jan 2026
President and CEO
Sold on a plan
34,799
$4.17
$145.11K
SMITH J. JEFFERSON
21 Jan 2026
Chief Research Officer
Sold after exercise
10,200
$4.03
$41.11K
Kelly John Alexander
21 Jan 2026
Chief Financial Officer
Sold on a plan
15,213
$4.03
$61.31K
Scimeca Dario
21 Jan 2026
General Counsel and Secretary
Sold on a plan
8,854
$4.03
$35.68K
Frankel Stanley
16 Dec 2025
Director
Buy
2,700
$4.70
$12.69K
Germano Geno J
16 Dec 2025
Director
Buy
3,000
$4.72
$14.16K
Brown Melinda
15 Dec 2025
Director
Buy
1,381
$4.97
$6.86K
Amoroso Michael
3 Nov 2025
President and CEO
Sold after exercise
3,409
$6.49
$22.12K
Scimeca Dario
3 Nov 2025
General Counsel and Secretary
Sold on a plan
665
$6.49
$4.32K
Kelly John Alexander
3 Nov 2025
Chief Financial Officer
Sold on a plan
1,303
$6.49
$8.46K
Frankel Stanley
26 Sep 2025
Director
Buy
2,700
$4.97
$13.42K
Brown Melinda
22 Sep 2025
Director
Buy
1,400
$4.89
$6.85K

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 462,817
History held since 29 Mar 2019